Substituted nucleosides, nucleotides and analogs thereof
Disclosed herein are nucleosides, nucleotides, and nucleotide analogs, methods of synthesis thereof, and methods of using one or more nucleosides, nucleotides, and nucleotide analogs to treat diseases and/or conditions, such as coronaviridae virus, taviridae virus, hepatitis viridae virus, and/or bunyaviridae virus infection..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 12. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
BLATT LAWRENCE M [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-12, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
CN117379452 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA001032755 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA001032755 | ||
| 003 | DE-627 | ||
| 005 | 20240329155839.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA001032755 | ||
| 035 | |a (EPA)CN117379452 | ||
| 035 | |a (EPA)54868668 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a BLATT LAWRENCE M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Substituted nucleosides, nucleotides and analogs thereof |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-12, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 | ||
| 520 | |a Disclosed herein are nucleosides, nucleotides, and nucleotide analogs, methods of synthesis thereof, and methods of using one or more nucleosides, nucleotides, and nucleotide analogs to treat diseases and/or conditions, such as coronaviridae virus, taviridae virus, hepatitis viridae virus, and/or bunyaviridae virus infection. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BEIGELMAN LEONID |4 aut | |
| 700 | 0 | |a SYMONS JULIAN ALEXANDER |4 aut | |
| 700 | 0 | |a SMITH DAVID BERNARD |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 12. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:12 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/54868668/publication/CN117379452A1?q=CN117379452 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 12 |c 01 | ||